| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd4e093cdc7736586aa9bf033427a098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96b4fe3966f6aab690b1220d8ab7ba6d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate |
2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac06c88b092013c07b56a22d20d3fced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a74ef0f138e042d130172f5b6197ace7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0eb934e9c78f75c725f5aa882d98e7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3cdb1c7c0f12b2c316d22f1bd96fc1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4cb667bb8001b74d4078bcce2c1066a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdbf9d6aee8a595bfdc00c8de351b174 |
| publicationDate |
2022-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022250107-A1 |
| titleOfInvention |
Human neutralizing antibody against wild-type strain and mutant strain of sars-cov-2, and antigen-binding fragment thereof |
| abstract |
The purpose of the present invention is to provide: a novel human-derived monoclonal antibody that binds to a spike (S) protein of a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to neutralize the SARS-CoV-2; an antigen-binding fragment of the antibody; and a pharmaceutical composition containing the antibody or an antigen-binding fragment thereof. The present invention provides: a human-derived monoclonal antibody against a SARS-CoV-2, which binds to an S protein of the SARS-CoV-2 to neutralize viral activities, including an immune escape mutation, of the SARS-CoV-2; an antigen-binding fragment of the antibody; nucleic acids respectively encoding the antibody and the antigen-binding fragment of the antibody; and a pharmaceutical composition for treating or preventing SARS-CoV-2 infection, which contains the antibody or an antigen-binding fragment thereof. |
| priorityDate |
2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |